Failure Mode and Effects Analysis (FMEA): Risk Table
Contents
Failure Mode and Effects Analysis (FMEA): Risk Table#
ISO 14971:2019 Section |
Document Section |
---|---|
5.2 |
(all; entries about reasonably foreseeable misuse) |
5.4 |
3 |
5.5 |
3, 4 |
6 |
3 |
7.1 |
4 |
7.2 |
4 |
7.3 |
4 |
7.5 |
4 |
IEC 62366-1:2015 Section |
Title |
Document Section |
---|---|---|
4.1.2 |
Risk Control as it relates to User Interface design |
4 |
5.3 |
Identify known or foreseeable Hazards and Hazardous Situations |
1,3 |
This is a Failure Mode and Effects Analysis (FMEA) of the device. It is separated into multiple sections:
Failure Modes lists everything which can go wrong
Hazards and Analysis lists everything (harms) which can subsequently happen, including an analysis of probability and severity
The list of Risk Control Measures which contains all control measures which were implemented for risk reduction, either reducing probability or severity, or both.
1. Preliminary Hazards Analysis (PHA)#
ID |
Source |
Description |
Hazard ID(s) |
1 |
Intended Use |
Avoidance organ under-contoured |
1 |
2 |
Intended Use |
Avoidance organ over-contouring |
2 |
3 |
Intended Use |
Target under-contouring |
3 |
4 |
Intended Use |
Target over-contouring |
4 |
5 |
Technical considerations |
No contour produced |
5 |
6 |
Technical considerations |
Delay in contour production |
6 |
7 |
Usability |
Contour misidentified |
7 |
8 |
IT Security |
Leakage of Patient Information |
8 |
2. Failure Modes#
ID |
Failure Mode |
Hazard ID(s) |
1 |
Incorrect contour |
1, 2, 3, 4, 5 |
2 |
Security breach |
8 |
3 |
Cloud server computation bottlenecks |
6 |
3. Hazards and Analysis#
ID |
Hazard |
p1 |
Hazardous Situation |
p2 |
Harm |
1 |
Avoidance organ under-contoured |
10^-5 |
Radiotherapy treatment plan created and delivered to the patient which irradiates the under-contoured region |
10^-3 |
Death or serious disablement |
2 |
Avoidance organ over-contouring |
10^-5 |
Radiotherapy treatment plan created and delivered to the patient which compromises too much on target |
10^-2 |
Reduced treatment outcomes |
3 |
Target under-contouring |
10^-3 |
Radiotherapy treatment plan created and delivered to the patient which compromises too much on target |
10^-2 |
Major treatment protocol deviation, significantly reduced treatment outcomes |
4 |
Target over-contouring |
10^-3 |
Radiotherapy treatment plan created and delivered to the patient where a compromise was needed between organ at risk and the target due to its over contouring |
10^-2 |
Increased treatment side-effects |
5 |
No contour produced |
10^-5 |
Radiotherapy treatment plan created and delivered to the patient irradiating the organ |
10^-2 |
Death or serious disablement |
6 |
Delay in contour production |
10^-2 |
Contour needs to be undergone manually following current standard practice |
10^-2 |
Delay in treatment |
7 |
Contour misidentified |
10^-5 |
Radiotherapy treatment plan created and delivered to the patient irradiating the organ |
10^-2 |
Death or serious disablement |
8 |
Leakage of Patient Information |
10^-6 |
Cloud server security breach |
10^-1 |
Patient identifying data leak |
ID |
p1*p2 |
P |
S |
Acceptable without risk controls? |
1 |
10^-8 |
P2 |
S5 |
No |
2 |
10^-7 |
P3 |
S3 |
Yes |
3 |
10^-5 |
P4 |
S4 |
No |
4 |
10^-5 |
P4 |
S2 |
Yes |
5 |
10^-7 |
P3 |
S5 |
No |
6 |
10^-4 |
P4 |
S1 |
Yes |
7 |
10^-7 |
P3 |
S5 |
No |
8 |
10^-7 |
P3 |
S3 |
Yes |
ID |
External Risk Control ID(s) |
P |
S |
Acceptable with external risk controls? |
1 |
1, 2 |
P1 |
S5 |
Yes |
2 |
1, 2 |
P1 |
S3 |
Yes |
3 |
1, 2 |
P2 |
S4 |
Yes |
4 |
1, 2 |
P2 |
S2 |
Yes |
5 |
1, 2 |
P1 |
S5 |
Yes |
6 |
P4 |
S1 |
Yes |
|
7 |
1, 2 |
P1 |
S5 |
Yes |
8 |
P3 |
S3 |
Yes |
ID |
Internal Risk Control ID(s) |
P |
S |
Acceptable with all risk controls? |
1 |
3 |
P1 |
S5 |
Yes |
2 |
3 |
P1 |
S3 |
Yes |
3 |
3 |
P1 |
S4 |
Yes |
4 |
3 |
P1 |
S2 |
Yes |
5 |
3 |
P1 |
S5 |
Yes |
6 |
P4 |
S1 |
Yes |
|
7 |
3 |
P1 |
S5 |
Yes |
8 |
4 |
P3 |
S2 |
Yes |
4. Risk Control Measures#
ID |
Description |
Type |
Probability Reduction |
Severity Reduction |
1 |
The contour data is provided to an independent software treatment planning system where that independent software is utilised for refinement and approval by a relevant qualified health practitioner. |
External measure – Health care procedure |
10^2 |
0 |
2 |
The subsequent refined contours are then reviewed by at least one other independent relevant qualified health practitioner. Generally however the whole plan, including the contours goes through multiple independent reviewers before being utilised for treatment. |
External measure – Health care procedure |
10^2 |
0 |
3 |
After the refinements have been completed they are sent back to the software. The level of refinements are then compared to the original model results and feedback on this compared to the standard amount of refinement generally undergone for that contour type is then provided via notification to an independent relevant qualified health practitioner. |
Internal measure – Information for safety |
10^2 |
0 |
4 |
All identifying patient information is deidentified prior to submitting the data to the cloud server |
Internal measure – Protective measure |
0 |
1 |